MREO DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Mereo BioPharma Group plc Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MREO
NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ:MREO) between June 5, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff […]